Jochen Rüdiger
Immediate non-invasive ventilatory (NIV) support in patients with severe respiratory failure on the emergency ward (ED)- Experience of a 6 months pilot
01.06.2013Background Patients with severe respiratory failure (SRF) are often in need for rapid ventilatory support. Availability of immediate NIV is often limited to the intensive care unit (ICU). We hypothesized that immediate initiation of NIV in the ED is...
Grundlagenforschung - 01.06.2013 - 01.01.2015
Abgeschlossen
Projektleitung: Rüdiger Jochen, Brutsche Martin
Mitarbeiter/innen: Kleger Gian-Reto, Diethelm Markus, Osterwalder Joseph
Improved adherence to CPAP by Telemetric Support in Newly diagnosed OSAS Patients
01.01.2013Introduction: The acceptance of positive airway pressure therapy (CPAP) within the first month is a critical aspect of successful OSAS therapy. Telemedicine is a novel tool to supervise CPAP use at patient's home. We report 30-day results of a pilot...
Grundlagenforschung - 01.01.2013 - 01.03.2013
Abgeschlossen
Projektleitung: Schoch Otto, Brutsche Martin
Mitarbeiter/innen: Baty Florent, Niedermann Jolanda, Rüdiger Jochen
The significance of Defensin alpha 4 in the pathophysiology of the adrenal insufficiency in inflammatory lung diseases
01.09.2012The pathophysiology of the adrenal insufficiency of patients with critical diseases remains unclear. In a prior exploratory study investigating patients with exacerbation of chronic obstructive pulmonary disease (COPD), we demonstrated a highly signi...
Grundlagenforschung - 01.09.2012 - 01.09.2013
Abgebrochen
Projektleitung: Rüdiger Jochen
Mitarbeiter/innen: Baty Florent, Bilz Stefan, Lehmann Natalie, Brutsche Martin
The obstructive pulmonary disease outcomes cohort of Switzerland (TOP DOCS): phenotypes and vascular amage in COPD
01.01.2012Prospective cohort study including COPD patients from 6 study centers in Northern Switzerland
Grundlagenforschung - 01.01.2012 - 31.12.2015
Automatisch geschlossen
Projektleitung: Brutsche Martin
Mitarbeiter/innen: Rüdiger Jochen, Burger Barbara, Haider Karin
A multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension
01.10.2009The primary objective is to demonstrate the effect of ACT-293987 on time to first clinical worsening in patients with pulmonary arterial hypertension (PAH)
Klinische Forschung - 01.10.2009 - 01.04.2013
Abgebrochen
Projektleitung: Brutsche Martin
Mitarbeiter/innen: Burger Barbara, Haider Karin, Rüdiger Jochen